The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure. Article uri icon

Overview

publication date

  • March 18, 2016

Research

keywords

  • Azacitidine
  • Models, Biological
  • Myelodysplastic Syndromes

Identity

PubMed Central ID

  • PMC5013943

Scopus Document Identifier

  • 84971529970

Digital Object Identifier (DOI)

  • 10.3324/haematol.2015.140962

PubMed ID

  • 26992944

Additional Document Info

volume

  • 101

issue

  • 6